Company / Free Cash Flow per Share
Exelixis Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$3.11
FY2025
5-year range
$0.56 / $3.11
FY2021-FY2025
Trend
+40.2%
vs FY2024
Sector context
#26 of 192
Health Care
What the data says
Exelixis's free cash flow per share of $3.11 is higher than 86% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has increased for 3 consecutive years, from $0.56 in FY2022 to $3.11 in FY2025.
Based on SEC 10-K filings.
3.11 in FY2025 with a 5-year CAGR of +39.6%. Top quartile in the Health Care sector.
Improved from $0.90 to $3.11 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +77.0%
- 5-Year CAGR
- +39.6%
- 10-Year CAGR
- -
Sector benchmark
-6.3% below sector average
Key checks
Key Insights
- Exelixis's free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 40.2% year-over-year.
- Ranks #26 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.11 | +40.2% |
| FY2024 | $2.22 | +145.3% |
| FY2023 | $0.90 | +61.4% |
| FY2022 | $0.56 | -66.0% |
| FY2021 | $1.65 | +181.5% |
| FY2020 | $0.59 | -65.8% |
| FY2019 | $1.71 | +143.3% |
| FY2018 | $0.70 | +41.4% |
| FY2017 | $0.50 | -45.6% |
| FY2016 | $0.92 | +226.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026